182541 Aromatase Inhibitor II, Letrozole - CAS 112809-51-5 - Calbiochem

182541
가격을 검색할 수 없습니다
Minimum Quantity needs to be mulitiple of
가격 문의 추가 정보
()이 할인됨
 
가격 문의
재고 없음재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service
      가격 및 재고 조회

      개요

      Replacement Information

      주요 사양표

      Empirical FormulaCAS #
      C₁₇H₁₁N₅ 112809-51-5

      가격 및 재고여부

      카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
      182541-25MGCN
      재고 정보 검색...
      재고 없음재고 없음
      예상 출고 가능일 
      단종품
      제한된 수량 가능
      재고여부 확인
        Remaining: will advise
          Remaining: will advise
          추천사항
          고객 서비스로 문의
          Contact Customer Service

          Glass bottle 25 mg
          가격 검색...
          가격을 검색할 수 없습니다
          Minimum Quantity needs to be mulitiple of
          가격 문의 추가 정보
          ()이 할인됨
           
          가격 문의
          Description
          OverviewAn orally bioavailable non-steroidal triazole compound that acts as a potent and selective inhibitor of aromatase (IC50 = 140, 350 and 450 pM in Dex-treated fibroblasts, MCF-7Ca, and JEG-3 cells, respectively). Competitively, but reversibly binds to the heme iron of aromatase. Does not affect the synthesis of adrenal mineralocorticoid or glucocorticoids. Reported to be highly effective as an anti-estrogenic and anti-proliferative agent in estrogen-rich tumors. Also delays the fusing of the growth plates in adolescents and enhances the effectiveness of growth hormone. Shown to synergistically induce apoptosis and cause tumor regression when combined with IGF-1R inhibitors.
          Catalogue Number182541
          Brand Family Calbiochem®
          Synonyms4,4ʹ-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile, 1-(bis-(4-Cyanophenyl)methyl)-1,2,4-triazole
          References
          ReferencesHou, X., et al. 2011. Cancer Res. 71, 7597.
          Lisztwan, J., et al. 2008. Breast Cancer Res. 10, R56.
          Miller, W.R., et al. 2002. Cancer Invest. 20 (Suppl 2), 15.
          Long, B.J., et al. 1998. J. Steroid Biochem. Molec. Biol. 67, 293.
          Product Information
          CAS number112809-51-5
          FormWhite powder
          Hill FormulaC₁₇H₁₁N₅
          Chemical formulaC₁₇H₁₁N₅
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Purity≥99% by HPLC
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Aromatase Inhibitor II, Letrozole - CAS 112809-51-5 - Calbiochem MSDS

          타이틀

          물질안전보건자료(MSDS) 

          Aromatase Inhibitor II, Letrozole - CAS 112809-51-5 - Calbiochem Certificates of Analysis

          TitleLot Number
          182541

          References

          참고문헌 보기
          Hou, X., et al. 2011. Cancer Res. 71, 7597.
          Lisztwan, J., et al. 2008. Breast Cancer Res. 10, R56.
          Miller, W.R., et al. 2002. Cancer Invest. 20 (Suppl 2), 15.
          Long, B.J., et al. 1998. J. Steroid Biochem. Molec. Biol. 67, 293.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision27-June-2012 JSW
          Synonyms4,4ʹ-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile, 1-(bis-(4-Cyanophenyl)methyl)-1,2,4-triazole
          DescriptionAn orally bioavailable non-steroidal triazole compound that acts as a potent and selective inhibitor of aromatase (IC50 = 140, 350 and 450 pM in Dex-treated fibroblasts, MCF-7Ca, and JEG-3 cells, respectively). Competitively, but reversibly binds to the heme iron of aromatase. Does not affect the synthesis of adrenal mineralocorticoid or glucocorticoids. Reported to be highly effective as an anti-estrogenic and anti-proliferative agent in estrogen-rich tumors. Also delays the fusing of the growth plates in adolescents and enhances the effectiveness of growth hormone. Shown to synergistically induce apoptosis and cause tumor regression when combined with IGF-1R inhibitors.
          FormWhite powder
          Intert gas (Yes/No) Packaged under inert gas
          CAS number112809-51-5
          Chemical formulaC₁₇H₁₁N₅
          Structure formulaStructure formula
          Purity≥99% by HPLC
          SolubilityDMSO (50 mg/ml; clear, colorless solution) or Ethanol (< 5 mg/ml; partially soluble)
          Storage +2°C to +8°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Toxicity Standard Handling
          ReferencesHou, X., et al. 2011. Cancer Res. 71, 7597.
          Lisztwan, J., et al. 2008. Breast Cancer Res. 10, R56.
          Miller, W.R., et al. 2002. Cancer Invest. 20 (Suppl 2), 15.
          Long, B.J., et al. 1998. J. Steroid Biochem. Molec. Biol. 67, 293.